European Medicines Agency has approved the Marketing Authorization Application of ALPROLIX by Biogen and Sobi. ALPROLIX, a recombinant factor IX Fc fusion protein product candidate for the treatment of hemophilia B. According to MAA, Phase 3 Trials for Efficacy, safety and pharmacokinetics tests would be done. Biogen and Sobi are collaborators in the development and commercialization […]
News: EMA Approves ALPROLIX Marketing $BIIB Read More »
Neuralstem Inc., shares up by 11% on the presentation of its Pre-market Pre-clinical data on “Human Neural Stem Cells Expressing IGF-1: A Novel Cellular Therapy for Alzheimer. The poster was presented at the International Society for Stem Cell Research Annual Meeting in Stockholm, Sweden. View the full release here.
News: Neuralstem Up on Alzheimer Data $CUR Read More »
According to UBS analysts, Murphy Oil has been downgraded from Neutral to Sell with the reduced price target of $41 from $45. Referring to firm’s capex cut this year, the production would decline by 2016. Absence of Large exploration is also a key factor in it. View the full release here.
News: Murphy Oil Downgraded by UBS $MUR Read More »
Total SA., Europe second Big Oil Company, has announced to its gas pipeline stake in the U.K.’s North Sea to ArcLight Capital Partners. The French Frig Network may be sold to US Energy giant for around $1 Billion Enterprise deal. ArchLight may invest through its affiliate, North Sea Midstream Partners. No comments about the above from
News: Total Selling UK Stake to ArcLight $TOT Read More »
The Finish Line, Inc., has announced its first quarter results for FY-2015-16, Ending 30th May 2015. The results shows Store Sales rose by 5.5% and EPS went up to $0.30 YoY. Quarterly Financial Highlights:- Net sales were $443.4 Million up by 9.1% YoY. GAAP Basis EPS was $0.30 up from $0.25. Fiscal Financial Highlights:- Merchandise inventories rose
Earnings: Finish Line Store Sales Up $FINL Read More »
